adagrasib

Italy

Drugs containing this active substance

  • KRAZATI

    It is used for the treatment of adults with an advanced or widespread type of lung cancer, called non-small cell lung cancer (NSCLC), when previous treatments have not been effective and the cancer cells have a specific mutation (KRAS G12C).

    Form: tablets, film-coated

    Active substance Dosage
    adagrasib -

    ATC: L01XX77

    Manufacturer: BRISTOL-MYERS SQUIBB PHARMA EEIG